Top news of the week: 11.01.2022.
Healthcare
Preparing for the Next Plague
SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges
How Biogen Fumbled Aduhelm, Its Once-Promising Alzheimer’s Drug
Early results were so impressive the company raced toward regulatory approval. But its decision to stop trials produced a therapy without proven efficacy that many patients aren’t taking; ...
Co. Partners to Test New Cancer Vaccines Research Report
H.C. Wainwright & Co. advised that it currently has a Buy rating on Genocea Biosciences Inc.
Verily links up with Sosei Heptares for GPCR drug discovery
Verily and Sosei Heptares are hitching their wagons to the rising star of G-protein-coupled receptors to develop new drugs for immune-based disorders.
AI Driven Drug Firm Partners With Merck Market Gainer
Shares of Absci Corp. rose 18% after the company reported it is collaborating with Merck & Co. to create enzymes using its deep-learning Integrated Drug Creation™ platform and Bionic ...
Crises can’t be dealt with until they are recognised
Crises can’t be dealt with until they are recognisedBy Robert Hewitt, MB BS, PhD, Biosample HubIf a crisis is recognised, it can be a powerful accelerator of change. But do we always ...
Covaxin: Doomed to the dugout or ready to join the field of vaccine options?
Will Covaxin make its way to the field, or is it doomed to the dugout in the United States? Merit, not politics or cronyism, should determine the outcome.
These 2021 Biotech Breakthroughs Will Shape the Future of Health and Medicine
2021 was a big year for biotechnology, and the top three advances made will impact the field for years—if not decades—to come.